[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334996-105":3,"doc-detail-334996-en":81,"detail-sidebar-cat-0-en-105":98},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","association-between-inflammatory-bowel-disease-and-the-risk-of-parenteral-malignancies-a-two-sample-mendelian-randomization-study","Association between inflammatory bowel disease and the risk of parenteral malignancies - A two-sample Mendelian randomization study","","Aim: Using Mendelian Randomization (MR) analysis to investigate the potential causal association between Inflammatory Bowel Disease (IBD) and the occurrence of parenteral malignancies, in order to provide some reference for the parenteral malignancy prevention in patients with IBD. Methods: Two-sample MR based on independent IBD-linked genetic variants from GWAS meta-analysis; outcomes from FinnGen and UK Biobank. IVW, weighted median, MR-Egger, heterogeneity (Cochran’s Q) and strength tests were used. Results and conclusions describe elevated odds for diffuse large B-cell lymphoma and skin cancers with further mechanism research needed.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/association-between-inflammatory-bowel-disease-and-the-risk-of-parenteral-malignancies-a-two-sample-mendelian-randomization-study/334996/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/association-between-inflammatory-bowel-disease-and-the-risk-of-parenteral-malignancies-a-two-sample-mendelian-randomization-study/334996.png","ImageObject",300,407,{"name":42,"@type":43},"Aria","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study’s main objective regarding IBD and parenteral malignancies?","Question",{"text":63,"@type":64},"To assess the potential causal association between inflammatory bowel disease and the occurrence of parenteral malignancies, providing reference for prevention in IBD patients.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the Mendelian Randomization analysis conducted?",{"text":68,"@type":64},"A two-sample MR design used independent genetic variants linked to IBD from GWAS meta-analysis, with malignancy cases and controls from FinnGen and UK Biobank release data.",{"name":70,"@type":61,"acceptedAnswer":71},"Which malignancies showed evidence of association with IBD in the MR results?",{"text":72,"@type":64},"Estimates from IVW indicated higher odds of diffuse large B-cell lymphoma; UC and CD showed potential associations with non-melanoma skin cancer and skin cancer, while further robustness testing supported the results’ relative stability.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334996,1790015003,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":86,"file_id":87,"file_url":88,"file_type":89,"file_size":90,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":91,"language":92,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":93,"faqs":94,"seo_title":95,"seo_description":12,"update_tm":96,"read_time":97,"preview_page_count":4},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Clinics 79 (2024) 100421  \njournal homepage: [https://www.journals.elsevier.com/clinics](https://www.journals.elsevier.com/clinics)  \n| Original articles\u003Cbr>Association between inﬂammatory bowel disease and the risk of parenteral malignancies: A two-sample Mendelian randomization study\u003Cbr>Peizhu Su, Yilin Wang, Huiwen Huang, Qinghua Lu, Qinyan Wu, Zhaotao Li* Department of Digestive Disease, The First People’s Hospital of Foshan City, Guangdong, P.R. China |  |  | |\n| --- | --- | --- | --- |\n| H I G H L I G H T S |  |  |  |\n| 􀀁 To provide some reference for parenteral malignancy prevention in patients with IBD.\u003Cbr>􀀁 IBD was potentially associated with diffuse large B-cell lymphoma and skin cancers.\u003Cbr>􀀁 Some information on preventing parenteral malignancies in IBD was provided.\u003Cbr>􀀁 Further studies are needed to explore mechanisms ofthe effect of IBD on skin cancers. |  |  |  |\n| A R T I C L E I N F O |  | A B S T R A C T |  |\n| Keywords:\u003Cbr>Inﬂammatory bowel disease Parenteral malignancies\u003Cbr>Skin cancer\u003Cbr>Mendelian randomization study Causal relationship |  | Aim: Using Mendelian Randomization (MR) analysis to investigate the potential causal association between Inﬂammatory Bowel Disease (IBD) and the occurrence of parenteral malignancies, in order to provide some reference for the parenteral malignancy prevention in patients with IBD.\u003Cbr>Methods: This was a two-sample MR study based on independent genetic variants strongly linked to IBD selected from the Genome-Wide Association Study (GWAS) meta-analysis carried out by the International Inﬂammatory Bowel Disease Genetics Consortium (IIBDGC). Parenteral malignancy cases and controls were obtained from the FinnGen consortium and the UK Biobank (UKB) release data. Inverse Variance Weighted (IVW), weighted median, MR-Egger, and strength test (F) were utilized to explore the causal association of IBD with parenteral malignancies. In addition, Cochran’s Q statistic was performed to quantify the heterogeneity of Instrumental Variables (IVs).\u003Cbr>Results: The estimates of IVW showed that patients with IBD had higher odds of diffuse large B-cell lymphoma (OR = 1.2450, 95% CI: 1.0311‒1.5034). UC had potential causal associations with non-melanoma skin cancer (all p \u003C 0.05), melanoma (OR = 1.0280, 95% CI: 0.9860‒1.0718), and skin cancer (OR = 1.0004, 95% CI: 1.0001‒1.0006). Also, having CD was associated with higher odds of non-melanoma skin cancer (all p \u003C 0.05) and skin cancer (OR = 1.0287, 95% CI: 1.0022‒1.0559). In addition, results of pleiotropy and heterogeneity tests indicated these results are relatively robust.\u003Cbr>Conclusions: IBD has potential causal associations with diffuse large B-cell lymphoma and skin cancers, which may provide some information on the prevention of parenteral malignancies in patients with IBD. Moreover, further studies are needed to explore the speciﬁc mechanisms ofthe effect of IBD on skin cancers. |  |\n\nIntroduction  \nInﬂammatory Bowel Disease (IBD) is an immune-mediated intestinal tract disease, including Crohn’s Disease (CD) and Ulcerative Colitis (UC), which is related to the complex interaction between the genetic, environmental, gut microbiome, and immune factors.1 Malignancy is now the second leading cause of mortality in patients with IBD.2 Due to the inﬂuencing of chronic inﬂammation in the gut, patients with IBD are more likely to develop Colorectal Cancer (CRC) and other intestinal malignancies, whereas the association between IBD and parenteral  \nmalignancies is unclear.3 Studies have shown that the majority of patients with IBD had parenteral malignancies, and the incidence was gradually increasing.4-6 With the widespread use of immunosuppressive therapy in IBD, the impaired immune environment of patients may weaken their defense against tumors, so systemic inﬂammation and long-term immunosuppression caused by IBD may lead to an increased risk of parenteral malignancy.5 In addition, the comorbidities and parenteral symptoms of IBD may incr","cbCaioZ5BFZSppYv","https://ap.wps.com/l/cbCaioZ5BFZSppYv","pdf",466810,7,"English","# Highlights\n## Purpose\n## Findings\n# Article Info\n## Abstract\n## Keywords\n# Introduction\n## Background on IBD and malignancy risk\n## Rationale for Mendelian Randomization\n# Methods\n## Study design and data sources\n## Statistical analyses\n# Results\n## Diffuse large B-cell lymphoma\n## Non-melanoma skin cancer and melanoma\n## Robustness checks (pleiotropy and heterogeneity)\n# Conclusions\n## Implications for prevention and future work","[{\"question\":\"What is the study’s main objective regarding IBD and parenteral malignancies?\",\"answer\":\"To assess the potential causal association between inflammatory bowel disease and the occurrence of parenteral malignancies, providing reference for prevention in IBD patients.\"},{\"question\":\"How was the Mendelian Randomization analysis conducted?\",\"answer\":\"A two-sample MR design used independent genetic variants linked to IBD from GWAS meta-analysis, with malignancy cases and controls from FinnGen and UK Biobank release data.\"},{\"question\":\"Which malignancies showed evidence of association with IBD in the MR results?\",\"answer\":\"Estimates from IVW indicated higher odds of diffuse large B-cell lymphoma; UC and CD showed potential associations with non-melanoma skin cancer and skin cancer, while further robustness testing supported the results’ relative stability.\"}]","Association between inflammatory bowel disease and the risk of parenteral malignancies - A two-sample Mendelian randomization study | PDF",1790009168,18,{"code":4,"msg":82,"data":99},[100,104,108,112,117,122,126,129,134,137,141],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":101,"show_sort_weight":102,"slug":103},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":105,"show_sort_weight":106,"slug":107},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":109,"show_sort_weight":110,"slug":111},"Exam",70,"exam",{"id":113,"doc_module":4,"doc_module_name":25,"category_name":114,"show_sort_weight":115,"slug":116},5,"Comic",60,"comic",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":119,"show_sort_weight":120,"slug":121},6,"Technology",50,"technology",{"id":91,"doc_module":4,"doc_module_name":25,"category_name":123,"show_sort_weight":124,"slug":125},"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":127,"slug":128},30,"research-report",{"id":130,"doc_module":4,"doc_module_name":25,"category_name":131,"show_sort_weight":132,"slug":133},9,"Religion & Spirituality",20,"religion-spirituality",{"id":132,"doc_module":4,"doc_module_name":25,"category_name":135,"show_sort_weight":132,"slug":136},"World Cup","world-cup",{"id":138,"doc_module":4,"doc_module_name":25,"category_name":139,"show_sort_weight":138,"slug":140},10,"Lifestyle","lifestyle",{"id":142,"doc_module":4,"doc_module_name":25,"category_name":143,"show_sort_weight":113,"slug":144},19,"General","general"]